A Giant Abdominal Aortic Aneurysm and a Massive Eye Hemorrhage Due to Advanced Atherosclerosis in an Eighty-Four Year Old Man~!2009-10-07~!2009-12-14~!2010-03-05~! [PDF]
Mohammad Otahbachi +4 more
openalex +1 more source
Sex and reproductive stage modify the effect of endogenous oestrogens on coronary atherosclerosis in rheumatoid arthritis. [PDF]
Karpouzas GA +6 more
europepmc +1 more source
Association of dyslipidaemia, chronic kidney disease and hypertension with carotid atherosclerosis in patients with type 2 diabetes mellitus [PDF]
Volha Vasilkova +3 more
openalex +1 more source
Foam cells: tracing the diverse cellular origins and their linked signaling pathways. [PDF]
Jiao X +6 more
europepmc +1 more source
Phospholipid transfer protein(PLTP) plays a critical role in forming a complex with kinase A (AURKA) and P65. This interaction facilitates phosphorylation of P65 at Ser536, leading to the activation of the NF‐κB signaling pathway. Ultimately, this leads to the upregulation of downstream cytokines, including IL‐6, IL‐8, and CSF‐1, which promotes M2 ...
Xinyue Liang +14 more
wiley +1 more source
Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis
Carlos M. Campos +13 more
openalex +2 more sources
955Early coronary arteries atherosclerosis in young patients with seronegative spondyloarthropathies, coronary computed tomography angiography study [PDF]
Patrycja Ozdowska +10 more
openalex +1 more source
Microglial lipid metabolic dysfunction drives neurodegeneration in glaucoma. We found loss of LRP1 causes lipid accumulation and inflammation. We developed alpinetin‐loaded nanoparticles (AlpNPs) that bind LRP1, activate the PPARγ‐LXRα‐ABCA1 pathway to restore lipid homeostasis, promote an anti‐inflammatory phenotype, and protect retinal ganglion cells,
Miao Wei +8 more
wiley +1 more source
Research Progress on the Association Between Sarcopenic Obesity and Atherosclerosis: Current Status and Challenges. [PDF]
Yang K +5 more
europepmc +1 more source
Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases
Mitochondrial dysfunction is central to metabolic diseases. Nanomedicine offers transformative approaches for restoring function via targeted delivery, responsive release, and multimodal therapy. This review outlines the pathological basis, nanocarrier design, organelle‐specific targeting, recent advances, and future clinical translation challenges ...
Ke Xu +9 more
wiley +1 more source

